Hyperbaric Oxygen Therapy Devices Market 2022 Production Analysis – Key Players Name up to 4 to 5

In 2022, it is anticipated that the market for devices used in hyperbaric oxygen therapy will be worth US$3.21 billion. The overall demand for hyperbaric oxygen therapy devices is anticipated to increase at a CAGR of 7.1% ****ween 2022 and 2032, reaching approximately US$ 6.37 billion by 2032 due to the growing use of hyperbaric oxygen therapy in wound healing and the increasing number of athletes driving up demand for HBOT.

The use of the hyperbaric oxygen therapy (HBOT) technique improves leukocyte performance, particularly at the site of a wound, and reduces the toxicity of cyanide and carbon monoxide (CO). One of the major factors anticipated to propel the market during the forecast period is the technology’s increasing acceptance on a global scale.

The primary reason for the rise in demand for devices for hyperbaric oxygen therapy is the rising number of dia****ic patients worldwide. As a result, the market will experience an upward trend over time. Additionally, the market is expected to grow as medical tourism rises. The government’s support and investment in the growing factors in the healthcare sector cannot be disregarded for the increase in demand. Additionally, this technology is now used to treat cancer patients as well as patients with brain injuries.

One of the key factors anticipated to accelerate the growth of the hyperbaric oxygen therapy device market over the course of the analysis is the regulatory approval for a number of indications, including pulmonary embolism, severe anaemia, decompression sickness, burns, and brain abscesses, to name a few of the thirteen approved indications. One of the main factors anticipated to fuel market growth during the forecast period is the rising use of hyperbaric oxygen therapy devices for the treatment of lung disease and prevention of reperfusion injury.

In 2022, a 34.0% market share for hyperbaric oxygen therapy devices is anticipated in North America. A large portion of the market for hyperbaric oxygen therapy devices is expected to be in North America, thanks to factors like the region’s expanding population and growing interest in wound healing procedures.

Key Takeaways from the Market Study

Global Hyperbaric Oxygen Therapy Devices Market was valued at US$ 3.21 Billion by 2022-end
From 2017 to 2021, Hyperbaric Oxygen Therapy Devices demand expanded at a CAGR of 4.2%
By product, monoplace hyperbaric oxygen therapy devices to acquire a revenue share of 54%.
By Application, the Wound Healing segment dominates the Hyperbaric Oxygen Therapy Devices Market with a CAGR of 31%.
Competitive Landscape

Players in the global Hyperbaric Oxygen Therapy Devices Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In May 2021, C?tisCare, a leading provider of multi-place hyperbaric services for trauma centers and acute care hospitals, announced the official launch of hyperbaric aware website and national campaign. C?tisCare aims to increase awareness about hyperbaric oxygen therapy to effectively deal with various chronic conditions.
In November 2019, AHA Hyperbarics introduced the AHA Flex V2, a new model of innovative high-pressure medical hyperbaric chambers that are specifically built to meet the growing need for HBOT safety and efficacy.
In July 2019, Unique Group, the world’s prominent advanced subsea, offshore, and life support solution providers, launched its next generation multiplace hyperbaric oxygen treatment chamber, ‘Uni-Heal 2200 hyperbaric oxygen treatment facility’.
In February 2019, new medical research conducted at the LSU Health New Orleans School of Medicine indicates that the procedure can be beneficial for the patients of Alzheimer’s, when conducted with other therapies or by itself.
Key companies profiled:

Cardinal Health, Mölnlycke Health Care, Acelity L.P. Inc. (3M), Lohmann & Rauscher GmbH & Co. KG, Smith & Nephew, ConvaTec Inc., DeRoyal Industries, Inc., HARTMANN, Medela LLC, Haromed Bvba (Belgium), Carilex Medical GmbH. Genadyne Biotechnologies, Inc., Cork Medical, LLC, Alleva Medical Ltd. (Devon Medical Products, and Argentum Medical, LLC

Information Source:
https://www.futuremarketinsigh....ts.com/reports/hyper

Neurointerventional Devices Market 2022 Production Analysis – Key Players Name up to 4 to 5

A new report by Future Market Insights (FMI) expects global neurointerventional devices market is expected to project a significant growth CAGR value of about 4.7% from 2022 to 2030.

Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age.

It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new products.

In addition, rising prevalence of ischemic stroke is also boosting the neurointerventional devices market. Being non-invasive in nature, these devices increase chances of survival during surgery, further fueling market growth. By 2030, a valuation of US$ 4.8 Bn is predicted for the market.

Global Neurointerventional Devices Market- Key Takeaways

North America shall be the market hegemon, holding a 40.7% market share from 2020–2030
Embolic coils to capture the majority share, carotid stents to surge in popularity
High incidence of cerebral aneurysm to accelerate adoption of coiling procedures
Presence of experienced surgeons shall accelerate hospital-grade neurointerventional device adoption
Competitive Intelligence

Some influential vendors within the landscape include: Stryker Corporation, Covidien Public Ltd., Penumbra Inc., Terumo Corporation, Johnson & Johnson Private Limited, Medtronic PLC, Boston Scientific Corporation and Abbott.

Players are emphasizing on expanding their businesses through partnerships, collaborations and mergers & acquisitions and participation in trade fairs. Many of them are also aligning with research institutes to augment their research capacities.

In August 2020, Stryker Corporation successfully launched its Surpass Evolve flow diverter after receiving FDA clearance in the U.S market. The device has already been in use in Europe since 2019.

In September 2020, Penumbra Inc. shall participate in the virtual Global Embolization Symposium & Technologies 2020 Conference. The company hopes to broaden its outreach and collaborate with other leading players to develop and launch new neurointerventional devices, thus expanding its existing product portfolio.

COVID-19’s Impact on the Market

With respect to neurological disorders, several hospitals and clinics have reported complications in severely or critically ill patients with co-morbidities. COVID-19 has the potential to affect the central and peripheral nervous systems. The virus invades the brain either through the olfactory system or a hematogenous route. Once inside, the virus may cause hypoxic and metabolic abnormalities.

In this light, the neurointerventional devices market is poised to remain afloat in the near-term forecast period. Significant increases in mechanical thrombectomies were reported since April 2020, with majority of the patients seeking treatment for acute strokes from large vessel occlusions (LVOs).

A series of case studies on over 200 COVID-19 positive patients in Wuhan, China, 36.4% of patients exhibited neurologic symptoms such as acute cerebrovascular events, muscle injury and impaired consciousness. In this context, the market is poised to experience an adrenaline rush in the short-run.

Key Market Segments Covered In Neurointerventional Devices Industry Research

By Product:

Embolic Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Embolic Protection Devices
Flow Diverters Devices
Intrasaccular Devices
Liquid Embolic
Balloons
Stent Retrievers
By Technique:

Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User:

Hospitals
Ambulatory Surgical Centers
By Region:

North America
Latin America
Western Europe
Eastern Europe
Japan
APEJ
Middle East and Africa (MEA)
Information Source:
https://www.futuremarketinsigh....ts.com/reports/neuro

Hospital Capacity Management Solutions Market 2022 Production Analysis – Key Players Name up to 4 to 5

According to a recent report by the highly regarded market research company Future Market Insight, the market for hospital capacity management solutions is expected to reach US$ 994 Mn by the end of 2020.

Hospitals have been forced to make significant investments in streamlining their operations due to the expansion of patient care caused by the high incidences of chronic and infectious diseases. Rapid technological progress in recent years has made it possible to incorporate artificial intelligence to improve healthcare. By minimising maintenance downtime and producing significant cost savings, the adoption of hospital capacity management solutions has ushered in a smooth workflow.

Hospitals all over the world are increasing their investments in real-time location systems (RTLS) and cloud-based monitoring solutions. The adoption of RTLS systems in healthcare settings is rising due to a number of benefits, including ****ter patient flow, quicker room turnover, throughput optimization, and automated occupancy and discharge. Effective asset management is made possible by it as well.

The demand for hospital capacity management solutions has only increased due to the ongoing coronavirus pandemic. The pandemic has increased the need to implement cloud-based solutions in the upcoming forecast period as the demand for point-of-care access to medical records has grown. Additionally, there is a growing need for wireless monitoring tools, which allows doctors to prescribe efficient treatments to infected patients without having to be in close proximity.

Key Takeaways from FMI’s Hospital Capacity Management Solutions Report

Manufacturers are emphasizing on integrated management solutions to facilitate multiple supervisory operations simultaneously
More than 30% of the hospital capacity management solutions needs are met by RTLS, attributed to the utilization of system-based crisis response and emergency management
North America and Europe collectively enjoyed 70% of the global hospital capacity management market revenue in 2019 while developing countries are seen as potential future investment hubs
Global hospital capacity management solutions market is slated to expand at a CAGR of 5% ****ween 2020 and 2030
Hospital Capacity Management Solutions Market- Key Trends

Mushrooming demand for enhanced healthcare facilities in the wake of rapidly evolving health complications is providing traction to hospital capacity management solutions since a long time
Implementation of technologically advanced hospital capacity management solutions is being advocated by governments, setting aside a major chunk of their budgets in streamlining hospital care
Hospitals are collaborating with leading software and IT companies to design and implement state-of-the-art capacity management solutions, thereby spurring high investment inflow
Hospital Capacity Management Solutions Market- Region-wise Analysis

Increasing adoption of e-health solutions, demand for reduction in labor costs and waiting time for patients is driving capacity management solutions across hospitals in North America and Europe
Brazil, India, China and South Africa are expected to experience a massive upsurge in the adoption of hospital capacity management solutions. Increase in ICT spending and high patient pool are the key drivers
Hospital Capacity Management Solutions Market- Competitive Landscape

A number of players have penetrated the hospital capacity management market landscape over the past few years. In this study, these players have been profiled according to their regional prominence.

In the Americas, the prominent players include STANLEY Healthcare, Sonitor Technologies Inc., Cerner Corporation, Epic Systems Corporation and TeleTracking Technologies, Inc. among others. The European landscape is dominated by two main players: Koninklijke Philips N.V and Acromed AG while the Asia-Pacific landscape contains Neusoft Corporation, JVS Group, INFINITT Healthcare Co Ltd and Infosys Limited.

All these players primarily focus on acquiring greater market shares by virtue of organic growth strategies such as expansion of product portfolios in the software sector. For instance, in May 2020, STANLEY Healthcare announced the incorporation of the Aero Scout RTLS certified by Cisco DNA Spaces.

In March 2020, Neusoft Medical Systems established a robust cloud-enabled platform in collaboration with the Kenyatta National Hospital in Nairobi to provide proper diagnosis to COVID-19 patients.

Hospital Capacity Management Solutions Market Taxonomy

Product Type

Workflow Management Solutions
Asset Management Solutions
Bed Management Solutions
Quality Patient Care Solutions
Real Time Location Systems (RTLS)
Event Driven Solutions
Online Registration Solutions
Attendance Management Tools
Event-Driven Patient Tracking
Others
Application

Standalone Solutions
Integrated Solutions
Delivery Mode

On-Premise
Cloud-based
Regions/Country

North America

U.S
Canada
Latin America

Mexico
Brazil
Peru
Others
Europe

EU-5
Nordic countries
BENELUX
Poland
Russia
South Asia

India
ASEAN
East Asia

China
Japan
Oceania

Australia
New Zealand
Middle East & Africa

GCC
Southern Africa
North Africa
Information Source:
https://www.futuremarketinsigh....ts.com/reports/hospi

First Aid Market 2022 Key Players, SWOT Analysis, Key Indicators and Forecast to 2032

Future Market Insights (FMI), in its latest report titled, “China First Aid Market Assessment and Opportunity 2014–2020”, projects the China first aid market to exhibit a CAGR of 6.3% ****ween 2015 and 2020. Adoption of aggressive promotional campaigns are key factors driving growth of the market.

The report is focused on basic first aid products such as adhesive bandages, disinfectants and gauzes. Though the basic wound care segment in China accounts for miniscule share of the overall wound care market in China, it is expected to witness significant growth over the next few years. Increasing awareness about non-traditional first-aid products among consumers in Tier 2 and Tier 3 cities is the prime driving factor for the market in the region.

As of 2014, basic first aid products accounted for less than 20% share of the overall wound care market in China. Strategies such as innovative product packaging along with aggressive market campaigning has led to surge in demand for these products in China. Government emphasis on healthcare policies, liberalization of policies related to distribution of licenses and FDI influx are other key driving factors of the first aid market in China. On the flipside, low healthcare expenditure and higher preference for Chinese traditional medicines among consumers is a major restraint for non-traditional wound care product manufacturers.

The report analyses the China first aid market in terms of sales revenue (US$ Mn) by product, cities and by retail sales channel and provides information regarding market dynamics, value chain, competitive landscape, current trends, market estimations and forecast.

On the basis of city, the China first-aid market has been segmented into Tier 1, Tier 2 and Tier 3 Cities. Among Tier 1 cities, Shanghai offers good market opportunities for first-aid products manufacturers. It is anticipated to generate 1.4X higher sales revenue by the end of the forecast period as compared to that in 2014. Disinfectant products are anticipated to account for over half of the sales revenue in Tier 1 cities, followed by gauzes and bandages respectively. Tier 2 cities are expected to generate 1.3X higher revenue than Tier 3 cities by the end of 2020.

Among retail sales channels, drugstores and pharmacies are key channels for sales of adhesive bandages. Hospitals are the key channel for sales of gauzes. Hospitals account for major share of retail sales in Tier 3 cities in China. Though drugstores, pharmacies and hospitals are key retail sales channels for adhesive bandages and gauzes, modern retail sales channel are the most preferred mode for sales of disinfectants. Hypermarkets and supermarkets account for over 60% share of retail sales of disinfectants.

By product type, the China first aid market has been segmented into adhesive bandages, gauzes and disinfectants (antiseptics). While disinfectants are projected to be the largest market segment throughout the forecast period, its presence is limited to Tier 1 and Tier 2 cities in China. The disinfectant products segment is anticipated to register a CAGR of 7.5% ****ween 2014 and 2020. Reckitt Benckiser and Walch are key players in this product segment. Organized players account for significant market share in the disinfectants products segment. Among products, gauzes (woven and non-woven) covers significant market in Tier 3 cities in China. Sales revenue of adhesive bandages is further segmented into butterfly stiches, transdermal bandages and special bandages. Transdermal bandages account for significant market share in the adhesive bandages segment.

Key players in the China first aid market include:

Johnson and Johnson
Winner Medical Group Co.
Reckitt Benckiser
Yunnan Baiyao
3M Company
Nepstar Drugstore
7-Eleven
Beijing Hualian Group
A.S Watson Group.
Key Segment By Product Type

Bandages
Gauzes
Disinfectants
Information Source:
https://www.futuremarketinsigh....ts.com/reports/china

Portable Cardiology Ultrasound Systems Market 2022 Industry Research, Segmentation, Key Players Analysis and Forecast to 2026

Portable cardiac ultrasound systems, also known as echocardiography or echocardiogram, are used to evaluate various types and stages of the heart. Ultrasound is used in echocardiography to visualise the structure and function of the heart and its blood vessels. Portable cardiology ultrasound systems, roughly the size of a laptop computer, have been developed for point-of-care cardiac assessment at the bedside or in the physician’s office to improve the accuracy of bedside physical examinations.

Because the heart is the most vital organ in the human body, it must be taken care of. As a result, cardiac ultrasound has become a popular application of ultrasound. In the last decade, cardiac ultrasound systems have become widely used as a tool to aid in the prevention of heart disease. This system also assists patients in detecting problems in the early stages of cardiovascular disease treatment.

Ultrasound equipment has become quite portable as a result of technological advances in recent years. Portable ultrasound machines are ideal for situations where there is limited space, mobility is required, or scanning must be performed in the field. Portable ultrasound machines are currently used in cardiac, radiation, endocrinology, and paediatric applications.

Portable Cardiology Ultrasound Systems Market: Drivers and Restraints

The growing elderly population and rise in cardiovascular disease worldwide are major driving forces in the portable cardiology ultra sound system market. The advancement in computer software that allows for improved imaging in a smaller package and helps shorten exam times by reducing the number of steps required is expected to drive the global market for portable cardiology ultrasound systems.

Portable cardiology ultra sound systems are easy to transport and take up little space, which will increase their market demand. Several professionals have also adopted portable cardiology ultrasound systems for diagnosis, which is expected to drive the global market. The high cost of portable cardiology ultrasound systems, combined with a scarcity of trained and experienced operators, may limit the market for portable cardiology ultrasound systems.

Portable Cardiology Ultrasound Systems Market: Overview

Over the forecast period, the global market for portable cardiology ultrasound systems is expected to grow rapidly. The portable cardiology ultrasound system market is divided into two categories based on technology: 2D ultrasound systems and 3D ultrasound systems. 3D ultrasound systems are expected to dominate the market in the near future.

The portable cardiology ultrasound system market is divided into hospitals, cardiovascular clinics, echocardiography and vascular laboratories, diagnostic laboratories, and ambulatory surgical centres based on end user. Cardiovascular clinics are expected to have the largest market share of portable cardiology ultrasound systems among end users.

Portable Cardiology Ultrasound Systems Market: Regional Overview

The global portable cardiology ultrasound system market is divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World. Because of the increasing market penetration of therapeutic ultrasound and the growing emphasis on minimally invasive procedures, Europe is expected to dominate the portable cardiology ultrasound system market.

Following Europe, North America dominates the portable cardiology ultrasound system with ultrasound market due to the presence of sophisticated healthcare infrastructure and increasing patient and healthcare professional awareness. Because of improved healthcare facilities and an increase in the number of cardiology diseases in the elderly, Asia Pacific is the fastest growing region for the portable cardiology ultrasound system market.

Portable Cardiology Ultrasound Systems Market: Key Players

Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Esaote Nasce, and Providian Medical are some of the key players in the portable cardiology ultrasound system market. Chison Medical Imaging, ALPINION Medical Systems, Medgyn Products, Inc., and Telemed Medical Systems are other prominent players in the portable cardiology ultrasound system market.

Information Source:
https://www.futuremarketinsigh....ts.com/reports/porta